MEDIO Stock Overview
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Medistim ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr246.75 |
| 52 Week High | kr305.00 |
| 52 Week Low | kr246.75 |
| Beta | 0.83 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | 48.65% |
| 5 Year Change | 220.45% |
| Change since IPO | 411.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| MEDIO | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0% | 1.2% | 2.5% |
| 1Y | n/a | -10.0% | 5.8% |
Return vs Industry: Insufficient data to determine how MEDIO performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how MEDIO performed against the UK Market.
Price Volatility
| MEDIO volatility | |
|---|---|
| MEDIO Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: MEDIO has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MEDIO's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 117 | Kari Krogstad | www.medistim.com |
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis.
Medistim ASA Fundamentals Summary
| MEDIO fundamental statistics | |
|---|---|
| Market cap | kr4.69b |
| Earnings (TTM) | kr97.61m |
| Revenue (TTM) | kr458.69m |
48.1x
P/E Ratio10.2x
P/S RatioIs MEDIO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEDIO income statement (TTM) | |
|---|---|
| Revenue | kr458.69m |
| Cost of Revenue | kr101.60m |
| Gross Profit | kr357.09m |
| Other Expenses | kr259.48m |
| Earnings | kr97.61m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.35 |
| Gross Margin | 77.85% |
| Net Profit Margin | 21.28% |
| Debt/Equity Ratio | 0% |
How did MEDIO perform over the long term?
See historical performance and comparison